BRIEF-SeQuent Scientific Acquires 7.5% Stake In Fendigo SA Through Unit
March 31 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* ACQUIRED 7.5% STAKE IN FENDIGO SA THROUGH UNIT* DEAL FOR EUR 551,075...
Neutral
or
SeQuent Scientific News & Analysis
-
-
BRIEF-India's Sequent Scientific Dec-Qtr Consol Net Profit Rises
Feb 3 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* INDIA'S SEQUENT SCIENTIFIC DEC-QUARTER CONSOL NET PROFIT 372.3 MILLION RUPEES VERSUS 203.1 MILLION RUPEES YEAR AGO* SEQUENT SCIENTIFIC...
-
BRIEF-SeQuent Scientific Gets Suitability Certificate For Its Generic API Diclazuril In The EU
Jan 28 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* GOT ‘CERTIFICATE OF SUITABILITY' FOR ITS GENERIC API DICLAZURIL IN THE EU...
-
BRIEF-Sequent Scientific Launches Citramox Suspension Injection In 10 European Countries
Dec 10 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* LAUNCHES CITRAMOX SUSPENSION INJECTION FOR CATTLE AND PIGS IN 10 EUROPEAN COUNTRIES...
-
BRIEF-SeQuent Scientific Launches Halofusol Oral Solution For Calves In 19 European Countries
Dec 1 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* LAUNCHES HALOFUSOL 0.5 MG/ML ORAL SOLUTION FOR CALVES IN 19 EUROPEAN COUNTRIES...
-
BRIEF-India's Sequent Scientific Sept-Quarter Consol PAT Falls
Nov 6 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* INDIA'S SEQUENT SCIENTIFIC SEPT-QUARTER CONSOL PAT 213.6 MILLION RUPEES VERSUS 244.7 MILLION RUPEES YEAR AGO* SEQUENT SCIENTIFIC...
-
BRIEF-SeQuent Scientific Acquires Incremental Stake Of 15% In Fendigo BV, A Unit Of Co
Oct 1 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* ACQUISITION OF INCREMENTAL STAKE OF 15% IN FENDIGO BV, A UNIT OF CO* DEAL FOR EUR 191,947.50...
-
BRIEF-Sequent Scientific Taps Kamal K Sharma As Chairman
Aug 25 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* TAPS KAMAL K SHARMA AS CHAIRMAN* CHAIRMAN GOPAKUMAR G. NAIR STEPS DOWN...
-
BRIEF-India's SeQuent Scientific March-Quarter Consol PAT Falls
May 12 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* MARCH-QUARTER CONSOL PAT 169 MILLION RUPEES VERSUS 171 MILLION RUPEES YEAR AGO* MARCH-QUARTER CONSOL REVENUE 3.01 BILLION RUPEES VERSUS...
-
BRIEF-Sequent Scientific Says Carlyle Group To Buy Stake In Co
May 8 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* CARLYLE GROUP ENTERS AGREEMENTS TO BUY MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED* TRANSACTION IS EXPECTED TO CLOSE IN Q3 OF 2020*...
-
BRIEF-Sequent Scientific Ltd -Capacity Expansion Project At Germany Plant Put On Hold
April 8 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* SEQUENT SCIENTIFIC LTD -FACTORY OPERATIONS ACROSS LOCATIONS WORLDWIDE ARE WORKING WITH REDUCED STAFF* SEQUENT SCIENTIFIC LTD -HAVE PUT...
-
BRIEF-India's SeQuent Scientific Gets WHO-Geneva Approval For Its Vizag Facility
March 12 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* ANNOUNCES WHO-GENEVA APPROVAL FOR ITS VIZAG FACILITY* GOT WHO-GENEVA APPROVAL FOR API PRAZIQUANTEL UNDER PRE-QUALIFICATION...
-
BRIEF-India's Sequent Scientific Sept Qtr Consol PAT Rises
Nov 13 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* SEPT QUARTER CONSOL PROFIT AFTER TAX 244.7 MILLION RUPEES VERSUS 155 MILLION RUPEES YEAR AGO* SEPT QUARTER CONSOL REVENUE FROM...
-
BRIEF-SeQuent Scientific Gets EIR From US FDA For Bengaluru Analytical Laboratory
Aug 20 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* GETS EIR FROM US FDA FOR ITS ANALYTICAL LABORATORY AT...
-
BRIEF-India's Sequent Scientific March-Qtr Consol Profit Falls
May 14 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* MARCH QUARTER CONSOL NET PROFIT 171.2 MILLION RUPEES VERSUS 4 BILLION RUPEES YEAR AGO* MARCH QUARTER CONSOL REVENUE FROM OPERATIONS...
-
BRIEF-Sequent Scientific Approves Appointment Of Rakesh Bhatnagar As CFO
March 26 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* APPROVED APPOINTMENT OF RAKESH BHATNAGAR AS CHIEF FINANCIAL OFFICER...
-
BRIEF-India's Sequent Scientific Posts Dec-Qtr Profit
Feb 1 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* DEC QUARTER CONSOL NET PROFIT 130.3 MILLION RUPEES VERSUS LOSS OF 94.6 MILLION RUPEES YEAR AGO* DEC QUARTER CONSOL REVENUE FROM...
-
BRIEF-Sequent Scientific's Sequent Research Gets EIR From USFDA For Analytical Lab At Mangalore
Dec 13 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* SEQUENT SCIENTIFIC - SEQUENT RESEARCH GETS ESTABLISHMENT INSPECTION REPORT FROM USFDA FOR LABORATORY AT MANGALORE Source: https://...
-
BRIEF-India's Sequent Scientific Sept-Qtr Profit Falls
Nov 2 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* SEPT QUARTER CONSOL NET PROFIT 152.3 MILLION RUPEES VERSUS PROFIT 292.4 MILLION RUPEES YEAR AGO* SEPT QUARTER CONSOL REVENUE FROM...
-
BRIEF-India's Sequent Scientific June Qtr Consol Profit Rises
Aug 9 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* JUNE QUARTER CONSOL PROFIT 44.8 MILLION RUPEES VERSUS PROFIT 22.5 MILLION RUPEES YEAR AGO* JUNE QUARTER CONSOL REVENUE FROM OPERATIONS...
-
BRIEF-Sequent Scientific Says Unit Received Approval For Manufacturing Unit In Turkey
Aug 2 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* SEQUENT SCIENTIFIC -ALIVIRA, UNIT OF CO, HAS RECEIVED EU GMP APPROVAL FROM BULGARIAN AUTHORITIES FOR MANUFACTURING UNIT IN TURKEY...
-
BRIEF-Sequent Scientific Says Solara Active Pharma Sciences Got Final Listing Approval From BSE, NSE
June 26 (Reuters) - Sequent Scientific Ltd SEQU.NS :* SOLARA ACTIVE PHARMA SCIENCES RECEIVED FINAL LISTING APPROVAL FROM BSE, NSE ON JUNE 25* SAYS SHARES OF SOLARA ISSUED PURSUANT TO...
-
BRIEF-India's Sequent Scientific March-Qtr Consol Profit Rises
May 24 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* MARCH QUARTER CONSOL NET PROFIT 4 BILLION RUPEES VERSUS PROFIT OF 68.2 MILLION RUPEES YEAR AGO* MARCH QUARTER CONSOL REVENUE FROM...
-
BRIEF-Sequent Scientific Says NCLT Approved Composite Scheme Between Co, Strides Shasun, Solara Active Pharma Sciences
March 23 (Reuters) - Sequent Scientific Ltd SEQU.NS :* NCLT APPROVED COMPOSITE SCHEME INVOLVING DEMERGER OF COMMODITY API BUSINESS OF STRIDES, HUMAN API BUSINESS OF CO INTO SOLARA...
-
BRIEF-India's Sequent Scientific Dec Qtr Consol Loss Narrows
Feb 9 (Reuters) - India's Sequent Scientific Ltd SEQU.NS :* DEC QUARTER CONSOL LOSS 84.8 MILLION RUPEES VERSUS LOSS 105.8 MILLION RUPEES YEAR AGO* DEC QUARTER CONSOL REVENUE FROM...
-
BRIEF-Sequent Scientific Gets Shareholders' Nod For Scheme Of Arrangement with Strides Shasun
Dec 28 (Reuters) - Sequent Scientific Ltd SEQU.NS :* GETS SHAREHOLDERS' NOD TO APPROVE SCHEME OF ARRANGEMENT BETWEEN STRIDES SHASUN, CO AND SOLARA ACTIVE PHARMA SCIENCES
-
BRIEF-India's Sequent Scientific posts Sept-qtr profit
Nov 9 (Reuters) - Sequent Scientific Ltd SEQU.NS :* Sept quarter profit 305.4 million rupees versus loss 44.5 million rupees year ago* Sept quarter revenue from operations 2.65 billion...
-
BRIEF-Sequent Scientific seeks shareholders' nod for appointment of Sharat Narasapur as joint MD
Aug 31 (Reuters) - Sequent Scientific Ltd SEQU.NS* Seeks shareholders' nod for appointment of Sharat Narasapur as joint managing director
-
BRIEF-India's Sequent Scientific posts June-qtr consol profit
Aug 3 (Reuters) - Sequent Scientific Ltd SEQU.NS* June quarter consol profit 22.5 million rupees versus loss 118.7 million rupees year ago* June quarter consol total income 2.64 billion...
-
BRIEF-SeQuent Scientific's Alivira registers 3 products in Ukraine
July 4 (Reuters) - Sequent Scientific Ltd SEQU.NS :* Says Alivira registers three (3) products in Ukraine* Says products have already been shipped to Ukraine and will be launched shortly...
-
BRIEF-India's Sequent Scientific posts March-qtr profit
May 23 (Reuters) - Sequent Scientific Ltd SEQU.NS :* March quarter profit 32.3 million rupees versus loss 3.2 million rupees year ago* March quarter total income 1.10 billion rupees versus 1...
-
BRIEF-Sequent Scientific says Alivira gets US FDA approval for Visakhapatnam facility
May 2 (Reuters) - Sequent Scientific Ltd SEQU.NS * Says Alivira has received US FDA approval for its animal health API facility at Visakhapatnam, Andhra Pradesh. Source text - Further...
-
BRIEF-Sequent Scientific says co gets members' nod for divestment of Naari Pharma
March 24 (Reuters) - Sequent Scientific Ltd SEQU.NS : * Says co gets members' nod for divestment of Naari Pharma Private Limited Source text: Further company coverage: SEQU.NS
-
BRIEF-Sequent Scientific Dec qtr consol loss narrows
Feb 10 (Reuters) - Sequent Scientific Ltd SEQU.NS * Consol dec quarter net loss 28.7 million rupees versus loss 109.1 million rupees year ago * Consol dec quarter total income from...
-
BRIEF-SeQuent Scientific names Sharat Narasapur as Joint MD
Nov 11 (Reuters) - SeQuent Scientific Ltd SEQU.NS * Gautam Kumar Das, joint MD, wil cease to be joint MD effective Jan 7 * Sharat Narasapur will be appointed as joint MD of co Source...
-
BRIEF-Sequent Scientific Sept posts qtr consol loss
Nov 10 (Reuters) - Sequent Scientific Ltd SEQU.NS * Sequent Scientific Ltd - sept quarter consol net loss 51.5 million rupees versus profit 53.5 million rupees year ago * Sequent...
-
BRIEF-SeQuent Scientific's unit Alivira completes acquisition of 70 pct stake in Brazil's Interchange
Aug 1 (Reuters) - SeQuent Scientific Ltd SEQU.NS : * Unit Alivira completes the acquisition of 70 percent stake in Interchange, Brazil * Further company coverage...
-
BRIEF-SeQuent Scientific says Karizoo Group to be integrated with co effective July 1
June 30 (Reuters) - SeQuent Scientific Ltd SEQU.NS :* Deal with Karizoo Group Spain has achieved closure and Karizoo Group will beintegrated and consolidated with...
-
BRIEF-SeQuent Scientific says US FDA suspended manufacturing license at Mahad unit for 15 days
June 16 (Reuters) - SeQuent Scientific Ltd SEQU.NS : * US FDA passed order to suspend manufacturing license at Mahad unit for 15 days from July 1 * Unit continues to operate and co...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
